Concurrently, diminished levels of anti-inflammatory cytokines, specifically IL-10, are observed mainly in patients with both MASLD and SAH, thereby further skewing the balance towards a pro-inflammatory state that may amplify the sensitivity of these regulatory systems (44). Here, IL10 is linked to metabolic dysfunction-associated steatotic liver disease.